Public Sector Pension Investment Board
PensionPosition in ACAD — Acadia Pharmaceuticals Inc
CIK 1396318
MONTREAL, A8
Position in ACAD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,970,921
-$1,601,106 QoQ
Shares Held
447,930
+3.4% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Public Sector Pension Investment Board holds $340,768,011 across 30 Biotechnology names. ACAD ranks #12 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
73,300 | $53,527,325 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,037 | $40,205,867 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
92,286 | $23,839,319 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
331,852 | $22,609,076 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
210,280 | $22,163,512 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
41,177 | $18,387,177 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
487,257 | $16,186,677 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
366,674 | $14,751,295 |
All Filings in ACAD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,970,921 | 447,930 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $11,572,027 | 433,247 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,392,323 | 486,988 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $9,107,975 | 422,252 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,485,058 | 390,431 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||